메뉴 건너뛰기




Volumn 33, Issue 1, 2005, Pages 80-82

Clinical outcome of long-term lamivudine treated chronic HBV infected and HIV/HBV coinfected patients [2]

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; TENOFOVIR;

EID: 15944381862     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2004.12.002     Document Type: Letter
Times cited : (2)

References (5)
  • 1
    • 0032953751 scopus 로고    scopus 로고
    • Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men
    • J.P. Colin, D. Cazals-Hatem, and M.A. Loriot Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men Hepatology 29 1999 1306 1310
    • (1999) Hepatology , vol.29 , pp. 1306-1310
    • Colin, J.P.1    Cazals-Hatem, D.2    Loriot, M.A.3
  • 2
    • 0032850214 scopus 로고    scopus 로고
    • Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus coinfected persons in a randomized, controlled study (CAESAR)
    • G.J. Dore, D.A. Cooper, and C. Barrett Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus coinfected persons in a randomized, controlled study (CAESAR) J Infect Dis 180 1999 607 613
    • (1999) J Infect Dis , vol.180 , pp. 607-613
    • Dore, G.J.1    Cooper, D.A.2    Barrett, C.3
  • 3
    • 0034993211 scopus 로고    scopus 로고
    • Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis Be antigen seroconversion rates: Results after 3 years of therapy
    • N.W.Y. Leung, C.L. Lai, and T.T. Chang Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis Be antigen seroconversion rates: results after 3 years of therapy Hepatology 33 2001 1527 1532
    • (2001) Hepatology , vol.33 , pp. 1527-1532
    • Leung, N.W.Y.1    Lai, C.L.2    Chang, T.T.3
  • 4
    • 0033012793 scopus 로고    scopus 로고
    • Efficacy of lamivudine in patients with hepatitis B e antigen-negative/HBV-DNA positive (precore mutant) chronic hepatitis B
    • N.C. Tassopoulos, R. Volpes, and G. Pastore Efficacy of lamivudine in patients with hepatitis B e antigen-negative/HBV-DNA positive (precore mutant) chronic hepatitis B Hepatology 29 1999 889 896
    • (1999) Hepatology , vol.29 , pp. 889-896
    • Tassopoulos, N.C.1    Volpes, R.2    Pastore, G.3
  • 5
    • 0036174368 scopus 로고    scopus 로고
    • Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort
    • L.M.M. Wolters, B.E. Niesters, M.E. Hansen, M.E. van der Ende, F.P. Kroon, and C. Richter Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort J Clin Virol 24 2002 173 181
    • (2002) J Clin Virol , vol.24 , pp. 173-181
    • Wolters, L.M.M.1    Niesters, B.E.2    Hansen, M.E.3    Van Der Ende, M.E.4    Kroon, F.P.5    Richter, C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.